应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
GCTK GlucoTrack, Inc.
未开盘 08-13 16:00:00 EDT
0.3655
-0.0113
-3.00%
盘后
0.3700
+0.0045
+1.23%
19:57 EDT
最高
0.4041
最低
0.3618
成交量
115.95万
今开
0.3690
昨收
0.3768
日振幅
11.23%
总市值
386.66万
流通市值
384.52万
总股本
1,058万
成交额
44.16万
换手率
11.02%
流通股本
1,052万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
GlucoTrack与White Lion Capital签署股票购买协议第一修正案——8月7日SEC文件披露
美股速递 · 08-11
GlucoTrack与White Lion Capital签署股票购买协议第一修正案——8月7日SEC文件披露
E.F. Hutton & Co. 担任 GlucoTrack 与 LŌKahi Therapeutics 战略业务合并独家财务顾问及约570万美元可转换票据融资独家配售代理
美股速递 · 07-18
E.F. Hutton & Co. 担任 GlucoTrack 与 LŌKahi Therapeutics 战略业务合并独家财务顾问及约570万美元可转换票据融资独家配售代理
GlucoTrack与Lōkahi Therapeutics获E.F. Hutton战略融资支持,助力合并完成及未来资本市场计划
美股速递 · 07-17
GlucoTrack与Lōkahi Therapeutics获E.F. Hutton战略融资支持,助力合并完成及未来资本市场计划
新闻更新:GlucoTrack, Inc. 与 Lokahi Therapeutics 完成战略业务合并
投资观察 · 07-17
新闻更新:GlucoTrack, Inc. 与 Lokahi Therapeutics 完成战略业务合并
更新:GlucoTrack与Lōkahi Therapeutics完成战略业务合并,建立由Lōkahi控制的上市平台
美股速递 · 07-17
更新:GlucoTrack与Lōkahi Therapeutics完成战略业务合并,建立由Lōkahi控制的上市平台
GlucoTrack与Lokahi合并:SEC文件披露后者股东将获19.99%合并后流通股
美股速递 · 07-16
GlucoTrack与Lokahi合并:SEC文件披露后者股东将获19.99%合并后流通股
新闻稿:Glucotrack与Lōkahi Therapeutics完成战略业务合并,建立Lōkahi控制的公开平台
投资观察 · 07-15
新闻稿:Glucotrack与Lōkahi Therapeutics完成战略业务合并,建立Lōkahi控制的公开平台
GlucoTrack宣布美国专利商标局对其植入式连续血糖监测平台专利申请发出核准通知
美股速递 · 07-08
GlucoTrack宣布美国专利商标局对其植入式连续血糖监测平台专利申请发出核准通知
GlucoTrack公司向FDA提交植入式持续血糖监测技术美国临床研究IDE申请
美股速递 · 05-08
GlucoTrack公司向FDA提交植入式持续血糖监测技术美国临床研究IDE申请
GlucoTrack提交新型植入式连续血糖监测技术美国临床研究IDE申请
美股速递 · 05-08
GlucoTrack提交新型植入式连续血糖监测技术美国临床研究IDE申请
GlucoTrack拟于第二季度初向FDA提交重大临床试验申请,瞄准2025年关键里程碑
美股速递 · 03-27
GlucoTrack拟于第二季度初向FDA提交重大临床试验申请,瞄准2025年关键里程碑
Glucotrack, Inc.盘中异动 急速下挫5.49%
市场透视 · 02-28
Glucotrack, Inc.盘中异动 急速下挫5.49%
Glucotrack, Inc.盘中异动 快速上涨7.29%
市场透视 · 2025-03-10
Glucotrack, Inc.盘中异动 快速上涨7.29%
Glucotrack, Inc.盘中异动 早盘股价大跌5.37%报0.323美元
市场透视 · 2025-03-04
Glucotrack, Inc.盘中异动 早盘股价大跌5.37%报0.323美元
Glucotrack, Inc.盘中异动 下午盘股价大跌5.45%报0.342美元
市场透视 · 2025-03-04
Glucotrack, Inc.盘中异动 下午盘股价大跌5.45%报0.342美元
Glucotrack, Inc.盘中异动 快速拉升7.01%
市场透视 · 2025-02-28
Glucotrack, Inc.盘中异动 快速拉升7.01%
Glucotrack, Inc.盘中异动 早盘股价大涨5.35%
市场透视 · 2025-02-26
Glucotrack, Inc.盘中异动 早盘股价大涨5.35%
Glucotrack, Inc.盘中异动 大幅下挫6.32%
市场透视 · 2025-02-25
Glucotrack, Inc.盘中异动 大幅下挫6.32%
Glucotrack, Inc.盘中异动 股价大跌5.64%
市场透视 · 2025-02-24
Glucotrack, Inc.盘中异动 股价大跌5.64%
Glucotrack, Inc.盘中异动 股价大跌6.10%报0.375美元
市场透视 · 2025-02-21
Glucotrack, Inc.盘中异动 股价大跌6.10%报0.375美元
加载更多
公司概况
公司名称:
GlucoTrack, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
GlucoTrack, Inc.于2010年5月18日根据特拉华州法律注册成立。该公司是一家医疗设备公司,专注于设计、开发和商业化新技术,供糖尿病和糖尿病前期患者使用。该公司目前正在开发两种产品:一种用于2型糖尿病和糖尿病前期患者的无创血糖监测仪,以及一种用于1型糖尿病和胰岛素依赖型2型糖尿病患者的植入式连续血糖监测仪。
发行价格:
--
{"stockData":{"symbol":"GCTK","market":"US","secType":"STK","nameCN":"GlucoTrack, Inc.","latestPrice":0.3655,"timestamp":1786651200000,"preClose":0.3768,"halted":0,"volume":1159450,"hourTrading":{"tag":"盘后","latestPrice":0.37,"preClose":0.3655,"latestTime":"19:57 EDT","volume":68299,"amount":25637.576807,"timestamp":1786665433702,"change":0.0045,"changeRate":0.012312,"amplitude":0.06156},"delay":0,"changeRate":-0.02998938428874743,"floatShares":10520400,"shares":10578800,"eps":-20.8752,"marketStatus":"未开盘","change":-0.0113,"latestTime":"08-13 16:00:00 EDT","open":0.369,"high":0.4041,"low":0.3618,"amount":441622.539476,"amplitude":0.112261,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-20.8752,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1786694400000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":0.3768,"preHourTrading":{"tag":"盘前","latestPrice":0.3612,"preClose":0.3768,"latestTime":"09:22 EDT","volume":33642,"amount":12589.8675273,"timestamp":1786627327531,"change":-0.0156,"changeRate":-0.041401,"amplitude":0.058386},"postHourTrading":{"tag":"盘后","latestPrice":0.37,"preClose":0.3655,"latestTime":"19:57 EDT","volume":68299,"amount":25637.576807,"timestamp":1786665433702,"change":0.0045,"changeRate":0.012312,"amplitude":0.06156},"volumeRatio":0.848369},"requestUrl":"/m/hq/s/GCTK","defaultTab":"news","newsList":[{"id":"1128122096","title":"GlucoTrack与White Lion Capital签署股票购买协议第一修正案——8月7日SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1128122096","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1128122096?lang=zh_cn&edition=full","pubTime":"2026-08-11 04:25","pubTimestamp":1786393511,"startTime":"0","endTime":"0","summary":"GlucoTrack, Inc.于8月7日提交SEC文件,宣布与White Lion Capital正式签署股票购买协议第一修正案。这一关键性调整进一步明确了双方合作条款,为后续资本运作铺平道路。此次修订在原有协议基础上进行了优化,凸显了GlucoTrack在融资策略上的灵活布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","GCTK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127560747","title":"E.F. Hutton & Co. 担任 GlucoTrack 与 LŌKahi Therapeutics 战略业务合并独家财务顾问及约570万美元可转换票据融资独家配售代理","url":"https://stock-news.laohu8.com/highlight/detail?id=1127560747","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127560747?lang=zh_cn&edition=full","pubTime":"2026-07-18 01:21","pubTimestamp":1784308913,"startTime":"0","endTime":"0","summary":"E.F. Hutton & Co. 在 GlucoTrack, Inc. 与 LŌKahi Therapeutics 的战略业务合并交易中,担任了独家财务顾问。与此同时,该公司还作为独家配售代理,负责了总额约570万美元的可转换票据融资事宜。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","GCTK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149382701","title":"GlucoTrack与Lōkahi Therapeutics获E.F. Hutton战略融资支持,助力合并完成及未来资本市场计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1149382701","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149382701?lang=zh_cn&edition=full","pubTime":"2026-07-17 20:06","pubTimestamp":1784289973,"startTime":"0","endTime":"0","summary":"GlucoTrack, Inc. 与 LŌKahi Therapeutics™ 宣布,已获得 E.F. Hutton & Co. 的战略融资支持,此项支持将与其近期完成的业务合并及未来的资本市场举措相协同。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GCTK","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104468463","title":"新闻更新:GlucoTrack, Inc. 与 Lokahi Therapeutics 完成战略业务合并","url":"https://stock-news.laohu8.com/highlight/detail?id=1104468463","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1104468463?lang=zh_cn&edition=full","pubTime":"2026-07-17 04:59","pubTimestamp":1784235582,"startTime":"0","endTime":"0","summary":"新泽西州拉瑟福德与加利福尼亚州拉霍亚,2026年7月16日——GlucoTrack, Inc.今日宣布,其与Lōkahi Therapeutics的战略业务合并已顺利完成。根据交易架构,Lōkahi Therapeutics将成为合并后公司的运营主体和控股业务,并利用GlucoTrack的公开市场平台来支持长期发展及获取资本。作为交易完成的一部分,Lōkahi Therapeutics的证券持有人获得了GlucoTrack普通股与可转换优先股的组合。届时,在完全摊薄基础上,并受交易相关融资及惯例调整的影响,Lōkahi Therapeutics的证券持有人将持有合并后公司约90%的股份。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GCTK","BK4082"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1109388470","title":"更新:GlucoTrack与Lōkahi Therapeutics完成战略业务合并,建立由Lōkahi控制的上市平台","url":"https://stock-news.laohu8.com/highlight/detail?id=1109388470","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1109388470?lang=zh_cn&edition=full","pubTime":"2026-07-17 04:58","pubTimestamp":1784235493,"startTime":"0","endTime":"0","summary":"GlucoTrack与Lōkahi Therapeutics已成功完成战略业务合并,此举建立了一个由Lōkahi Therapeutics控制的公开上市平台。该合并标志着两家公司资源与战略的整合,旨在通过新的公共架构推动业务发展与创新。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GCTK","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137164516","title":"GlucoTrack与Lokahi合并:SEC文件披露后者股东将获19.99%合并后流通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1137164516","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1137164516?lang=zh_cn&edition=full","pubTime":"2026-07-16 05:26","pubTimestamp":1784150777,"startTime":"0","endTime":"0","summary":"根据最新提交给美国证券交易委员会的文件,在GlucoTrack, Inc.与Lokahi的合并交易完成之日,Lokahi的现有股东将获得相当于GlucoTrack届时已发行普通股总量19.99%的股份。这份文件明确了合并后公司的股权分配结构。此次股权安排是双方达成合并协议的关键条款之一,旨在为Lokahi股东提供在合并后实体中的直接权益。股权比例的计算基准将基于合并生效当日GlucoTrack的实际流通股数。具体的合并时间表及其他财务细节,预计将在后续公告中进一步披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GCTK","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182696709","title":"新闻稿:Glucotrack与Lōkahi Therapeutics完成战略业务合并,建立Lōkahi控制的公开平台","url":"https://stock-news.laohu8.com/highlight/detail?id=1182696709","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1182696709?lang=zh_cn&edition=full","pubTime":"2026-07-15 05:45","pubTimestamp":1784065528,"startTime":"0","endTime":"0","summary":"Glucotrack, Inc.今日宣布,其与Lōkahi Therapeutics的战略业务合并已正式完成。本次交易的结构设计使得Lōkahi Therapeutics成为合并后公司的运营及控制主体,并利用Glucotrack的公开市场平台来支持长期增长及资本获取。在交易完成之际,Lōkahi Therapeutics的证券持有人获得了Glucotrack普通股与可转换优先股的组合。届时,在完全稀释基础上,并受交易相关融资及常规调整影响,Lōkahi Therapeutics的证券持有人将持有合并后公司约90%的股份。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LENZ","BK4007","GCTK","BK4539","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181698440","title":"GlucoTrack宣布美国专利商标局对其植入式连续血糖监测平台专利申请发出核准通知","url":"https://stock-news.laohu8.com/highlight/detail?id=1181698440","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1181698440?lang=zh_cn&edition=full","pubTime":"2026-07-08 20:03","pubTimestamp":1783512205,"startTime":"0","endTime":"0","summary":"GlucoTrack, Inc. 宣布,美国专利商标局已就一项覆盖其植入式连续血糖监测平台的专利申请,发出了核准通知书。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","GCTK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102827968","title":"GlucoTrack公司向FDA提交植入式持续血糖监测技术美国临床研究IDE申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1102827968","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1102827968?lang=zh_cn&edition=full","pubTime":"2026-05-08 04:57","pubTimestamp":1778187432,"startTime":"0","endTime":"0","summary":"医疗科技企业GlucoTrack, Inc.近日通过美国证券交易委员会披露,已正式向食品药品监督管理局递交植入式持续血糖监测系统的研究用器械豁免申请。该申请旨在启动针对创新型CBGM技术的美国本土临床研究计划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","GCTK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114617467","title":"GlucoTrack提交新型植入式连续血糖监测技术美国临床研究IDE申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1114617467","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114617467?lang=zh_cn&edition=full","pubTime":"2026-05-08 01:01","pubTimestamp":1778173279,"startTime":"0","endTime":"0","summary":"GlucoTrack, Inc.宣布已正式向美国监管机构提交其创新植入式连续血糖监测技术的临床试验器械豁免(IDE)申请。该技术突破将为企业在美国开展关键临床研究铺平道路,标志着公司糖尿病管理解决方案商业化进程迈出重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GCTK","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110991922","title":"GlucoTrack拟于第二季度初向FDA提交重大临床试验申请,瞄准2025年关键里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=1110991922","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1110991922?lang=zh_cn&edition=full","pubTime":"2026-03-27 20:04","pubTimestamp":1774613078,"startTime":"0","endTime":"0","summary":"基于2025年的关键里程碑规划,GlucoTrack, Inc.计划在第二季度初向美国食品药品监督管理局(FDA)提交一项重要的临床试验申请(IDE),为其在美国开展临床研究铺平道路。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","GCTK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614890041","title":"Glucotrack, Inc.盘中异动 急速下挫5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614890041","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2614890041?lang=zh_cn&edition=full","pubTime":"2026-02-28 00:01","pubTimestamp":1772208077,"startTime":"0","endTime":"0","summary":"北京时间2026年02月28日00时01分,Glucotrack, Inc.股票出现异动,股价快速跳水5.49%。Glucotrack, Inc.股票所在的医疗设备行业中,整体跌幅为1.16%。其相关个股中,登士柏、Biolife Solutions, Inc.、Anbio Biotechnology涨幅较大,登士柏、Microbot Medical Inc.、Zentek Ltd.较为活跃,换手率分别为2.49%、1.76%、1.43%,振幅较大的相关个股有登士柏、Sharps Technology Inc C/Wts 、Anbio Biotechnology,振幅分别为11.61%、10.82%、10.16%。Glucotrack, Inc.公司简介:GlucoTrack Inc 是一家医疗器械公司。该公司已开发出可实时测量血糖水平的 GlucoTrack 模型。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022800011797a75a20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022800011797a75a20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GCTK","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518271830","title":"Glucotrack, Inc.盘中异动 快速上涨7.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518271830","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518271830?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:05","pubTimestamp":1741619109,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时05分,Glucotrack, Inc.股票出现异动,股价急速拉升7.29%。Glucotrack, Inc.股票所在的医疗设备行业中,整体跌幅为2.27%。其相关个股中,Sharps Technology Inc C/Wts 、Sharps Technology Inc.、Innovative Eyewear Inc C/Wts 16/08/2027 Ser A涨幅较大,Sharps Technology Inc.、Glucotrack, Inc.、Staar Surgical Company较为活跃,换手率分别为2780.94%、2.86%、0.97%,振幅较大的相关个股有Sharps Technology Inc C/Wts 、Sharps Technology Inc.、Innovative Eyewear Inc C/Wts 16/08/2027 Ser A,振幅分别为557.50%、84.26%、20.53%。Glucotrack, Inc.公司简介:GlucoTrack Inc 是一家医疗器械公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310230509abf31f2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310230509abf31f2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GCTK","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516339677","title":"Glucotrack, Inc.盘中异动 早盘股价大跌5.37%报0.323美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516339677","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516339677?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:35","pubTimestamp":1741098931,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时35分,Glucotrack, Inc.股票出现异动,股价大幅下挫5.37%。截至发稿,该股报0.323美元/股,成交量9.549万股,换手率0.92%,振幅2.11%。Glucotrack, Inc.股票所在的医疗设备行业中,整体跌幅为0.72%。其相关个股中,Innovative Eyewear Inc C/Wts 16/08/2027 Ser A、Nexgel, Inc、Staar Surgical Company涨幅较大,Sharps Technology Inc.、Glucotrack, Inc.、Microbot Medical Inc.较为活跃,换手率分别为1.23%、0.93%、0.56%,振幅较大的相关个股有Zentek Ltd.、ICU医疗、Sharps Technology Inc.,振幅分别为9.50%、4.67%、4.66%。Glucotrack, Inc.公司简介:GlucoTrack Inc 是一家医疗器械公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223531963945cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223531963945cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GCTK","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516652813","title":"Glucotrack, Inc.盘中异动 下午盘股价大跌5.45%报0.342美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516652813","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516652813?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:28","pubTimestamp":1741026514,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时28分,Glucotrack, Inc.股票出现波动,股价急速下挫5.45%。截至发稿,该股报0.342美元/股,成交量37.1841万股,换手率3.57%,振幅6.81%。Glucotrack, Inc.股票所在的医疗设备行业中,整体涨幅为1.41%。其相关个股中,Zentek Ltd.、Biolife Solutions, Inc.、Pro-Dex, Inc.涨幅较大,Sharps Technology Inc.、Predictive Oncology Inc.、Bionano Genomics, Inc.较为活跃,换手率分别为13.95%、9.89%、4.29%,振幅较大的相关个股有Predictive Oncology Inc.、Sharps Technology Inc.、Pro-Dex, Inc.,振幅分别为16.55%、15.24%、14.00%。Glucotrack, Inc.公司简介:GlucoTrack Inc 是一家医疗器械公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304022834a25d83e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304022834a25d83e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","GCTK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514376364","title":"Glucotrack, Inc.盘中异动 快速拉升7.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514376364","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514376364?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:30","pubTimestamp":1740756650,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时30分,Glucotrack, Inc.股票出现波动,股价大幅拉升7.01%。Glucotrack, Inc.股票所在的医疗设备行业中,整体跌幅为0.01%。其相关个股中,奥瑞许科技、Glucotrack, Inc.、Nexgel Inc C/Wts 27/12/2026 涨幅较大,Sharps Technology Inc.、Microbot Medical Inc.、Glucotrack, Inc.较为活跃,换手率分别为4.54%、2.17%、1.99%,振幅较大的相关个股有Pulse Biosciences, Inc、Nexgel, Inc、Sharps Technology Inc.,振幅分别为12.60%、9.47%、9.01%。Glucotrack, Inc.公司简介:GlucoTrack Inc 是一家医疗器械公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228233050a25810ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228233050a25810ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","GCTK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514068851","title":"Glucotrack, Inc.盘中异动 早盘股价大涨5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514068851","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514068851?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:51","pubTimestamp":1740581496,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时51分,Glucotrack, Inc.股票出现波动,股价大幅拉升5.35%。Glucotrack, Inc.股票所在的医疗设备行业中,整体涨幅为0.33%。其相关个股中,Predictive Oncology Inc.、Embecta Corp.、Sharps Technology Inc.涨幅较大,Sharps Technology Inc.、Glucotrack, Inc.、Microbot Medical Inc.较为活跃,换手率分别为5.04%、2.86%、1.06%,振幅较大的相关个股有Innovative Eyewear Inc C/Wts 16/08/2027 Ser A、奥瑞许科技、Nexgel, Inc,振幅分别为23.77%、17.10%、6.87%。Glucotrack, Inc.公司简介:GlucoTrack Inc 是一家医疗器械公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262251379893aefd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262251379893aefd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","GCTK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514090654","title":"Glucotrack, Inc.盘中异动 大幅下挫6.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514090654","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514090654?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:32","pubTimestamp":1740493944,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时32分,Glucotrack, Inc.股票出现异动,股价大幅跳水6.32%。Glucotrack, Inc.股票所在的医疗设备行业中,整体跌幅为0.95%。其相关个股中,美华国际、哈佛生物科学、Femasys Inc.涨幅较大,Sharps Technology Inc.、Microbot Medical Inc.、Glucotrack, Inc.较为活跃,换手率分别为2.32%、0.69%、0.61%,振幅较大的相关个股有Precision Optics Corporation, Inc.、Zentek Ltd.、Femasys Inc.,振幅分别为10.55%、7.25%、5.56%。Glucotrack, Inc.公司简介:GlucoTrack Inc 是一家医疗器械公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223224abdc7e27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223224abdc7e27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","BK4539","BK4584","FEMY","GCTK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513720555","title":"Glucotrack, Inc.盘中异动 股价大跌5.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720555","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513720555?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:52","pubTimestamp":1740408739,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时52分,Glucotrack, Inc.股票出现异动,股价大幅跳水5.64%。Glucotrack, Inc.股票所在的医疗设备行业中,整体涨幅为0.51%。Glucotrack, Inc.公司简介:GlucoTrack Inc 是一家医疗器械公司。该公司开发了一种无创血糖监测仪——GlucoTrack 型号 DF-F 血糖监测仪,旨在帮助糖尿病患者和糖尿病前期患者获得血糖水平读数,并免去传统点指尖采血设备的痛苦、不便和困难。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225219abdb12f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225219abdb12f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","GCTK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513291481","title":"Glucotrack, Inc.盘中异动 股价大跌6.10%报0.375美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513291481","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513291481?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:33","pubTimestamp":1740148401,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时33分,Glucotrack, Inc.股票出现波动,股价大幅下跌6.10%。截至发稿,该股报0.375美元/股,成交量11.6426万股,换手率1.12%,振幅7.38%。Glucotrack, Inc.股票所在的医疗设备行业中,整体跌幅为0.30%。其相关个股中,Zentek Ltd.、Nephros, Inc.、Warby Parker Inc.涨幅较大,Sharps Technology Inc.、Glucotrack, Inc.、Microbot Medical Inc.较为活跃,换手率分别为21.87%、1.24%、0.38%,振幅较大的相关个股有Sharps Technology Inc.、Glucotrack, Inc.、Nexgel, Inc,振幅分别为7.61%、7.38%、5.56%。Glucotrack, Inc.公司简介:GlucoTrack Inc 是一家医疗器械公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223321a24eb0c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223321a24eb0c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","GCTK"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.integrity-app.com","stockEarnings":[{"period":"1week","weight":-0.2248},{"period":"1month","weight":-0.3092},{"period":"3month","weight":-0.4377},{"period":"6month","weight":-0.7785},{"period":"1year","weight":-0.937},{"period":"ytd","weight":-0.9056}],"compareEarnings":[{"period":"1week","weight":0.0121},{"period":"1month","weight":0.0346},{"period":"3month","weight":0.0524},{"period":"6month","weight":0.141},{"period":"1year","weight":0.2062},{"period":"ytd","weight":0.1407}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"GlucoTrack, Inc.于2010年5月18日根据特拉华州法律注册成立。该公司是一家医疗设备公司,专注于设计、开发和商业化新技术,供糖尿病和糖尿病前期患者使用。该公司目前正在开发两种产品:一种用于2型糖尿病和糖尿病前期患者的无创血糖监测仪,以及一种用于1型糖尿病和胰岛素依赖型2型糖尿病患者的植入式连续血糖监测仪。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.283543},{"month":2,"riseRate":0.375,"avgChangeRate":-0.064968},{"month":3,"riseRate":0.375,"avgChangeRate":-0.278807},{"month":4,"riseRate":0.625,"avgChangeRate":0.152362},{"month":5,"riseRate":0.125,"avgChangeRate":-0.092656},{"month":6,"riseRate":0.222222,"avgChangeRate":-0.108439},{"month":7,"riseRate":0.444444,"avgChangeRate":0.018512},{"month":8,"riseRate":0.222222,"avgChangeRate":-0.024315},{"month":9,"riseRate":0.625,"avgChangeRate":0.152897},{"month":10,"riseRate":0.125,"avgChangeRate":-0.163128},{"month":11,"riseRate":0.375,"avgChangeRate":-0.123827},{"month":12,"riseRate":0.5,"avgChangeRate":0.25507}],"exchange":"NASDAQ","name":"GlucoTrack, Inc.","nameEN":"GlucoTrack, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GlucoTrack, Inc.(GCTK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供GlucoTrack, Inc.(GCTK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"GlucoTrack, Inc.,GCTK,GlucoTrack, Inc.股票,GlucoTrack, Inc.股票老虎,GlucoTrack, Inc.股票老虎国际,GlucoTrack, Inc.行情,GlucoTrack, Inc.股票行情,GlucoTrack, Inc.股价,GlucoTrack, Inc.股市,GlucoTrack, Inc.股票价格,GlucoTrack, Inc.股票交易,GlucoTrack, Inc.股票购买,GlucoTrack, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GlucoTrack, Inc.(GCTK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供GlucoTrack, Inc.(GCTK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}